Acutaas Chemicals Limited delivered a standout fourth quarter for FY26, with net profit more than doubling year-on-year and operating cash flow surging to nearly 2.5 times last year’s level — a combination that signals genuine operating leverage rather than accounting-driven earnings flattery.
The numbers
| Metric | Q4 FY26 | QoQ Change | YoY Change |
|---|---|---|---|
| Total Income | Rs 443.86 Cr | +11.55% | +41.24% |
| Net Profit | Rs 134.28 Cr | +26.42% | +114.11% |
| EPS | Rs 16.09 | +21.99% | +106.28% |
The headline that stands out is profit growing at 114% against revenue growth of 41% — a gap of over 70 percentage points that is the clearest possible signal of operating leverage kicking in. As a specialty chemicals company scales its revenue base, the fixed cost infrastructure — plant, equipment, regulatory overheads — gets better absorbed, and incremental margins on new revenue are significantly higher than the blended average. That dynamic is visibly playing out at Acutaas.
EPS at Rs 16.09 for the quarter has more than doubled year-on-year and grown 22% sequentially — a trajectory that, if sustained through FY27, would make the current valuation look materially different in hindsight.
The cash flow story — the most important number in the results
For specialty chemicals companies, operating cash flow is the acid test of whether reported profits are real. Acutaas passed that test emphatically. Operating cash flow for Q4 FY26 came in at Rs 292.17 crore against Rs 118.34 crore in the same quarter last year — a 147% year-on-year jump that significantly exceeds even the strong profit growth rate. This means the business is not just reporting better numbers — it is collecting cash faster, managing working capital better, and converting earnings into actual liquidity at an accelerating pace.
Investing outflows increased to Rs 265.94 crore from Rs 223.94 crore — reflecting continued capital expenditure that confirms the company is reinvesting in capacity to sustain its growth trajectory. Financing inflows fell sharply to Rs 4.10 crore from Rs 261.12 crore — a sign that the company is no longer relying on external capital to fund its operations, which is a mark of a business becoming self-financing through its own cash generation. Cash and equivalents stood at Rs 215.55 crore at quarter end.
The dividend
The board declared a dividend of Rs 2.50 per share — modest in yield terms but a confirmation of capital allocation discipline alongside the ongoing investment cycle.
The combination of 41% revenue growth, 114% profit growth, 147% operating cash flow growth and reducing dependence on external financing puts Acutaas firmly in the category of specialty chemical companies that are compounding quality — not just size.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making investment decisions.